Kyntra Bio

KYNBNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$29.478 M

$7.28 +1.11%

Close of 22 Sept 2026

Revenue

$6.44M

#3241 by revenue

Earnings

$183.5M

#1044 by earnings

Shares outstanding

4,049,124

Latest filing cover page

P/E ratio

0.2

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#378Transcode TherapeuticsRNAZ$30.0M
#379Quantum BiopharmaQNTM$29.9M
#380Kyntra BioKYNB$29.5M
#381IGC PharmaIGC$29.3M
#382China PharmaCPHI$28.8M

What if Kyntra Bio were worth as much as…

Open the what-if tool →

Gold $30.2T

$7,466,793

Per share 1,025,658× higher

Bitcoin $1.74T

$430,131.32

Per share 59,084× higher

Nvidia $5.52T

$1,362,212

Per share 187,117× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Kyntra Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.